Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The COX17 cytochrome c oxidase assembly homolog pseudogene (ENSG00000250213) is a non-protein-coding genomic sequence similar to the functional COX17 gene, which encodes a mitochondrial copper chaperone essential for cytochrome c oxidase assembly. The pseudogene is located on human chromosome 13 and contains several mutations, including in the putative copper binding domain, that render it non-functional. While the protein-coding COX17 gene is ubiquitously expressed and participates in mitochondrial copper homeostasis and electron transport chain function, the pseudogene itself has no known biological activity or relevance as a therapeutic target. Confusion between this pseudogene and the functional gene may occur, but only the latter has verified biological roles, potential disease relevance, and drug-response associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COX17 cytochrome c oxidase assembly homolog pseudogene (COX17P).